Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Why is AstraZeneca (LSE:AZN) in focus after its third-quarter 2026 results?

AstraZeneca published its results for the nine months and third quarter of 2026 on the London Stock Exchange. Third-quarter total revenue was USD 16,209m, up 7% on both a reported basis and at constant exchange rates (CER). Product sales rose 5% to USD 15,066m, …

Ankur Sharma | 30 October 2026

HUTCHMED (LSE:HCM) wins US FDA orphan drug designation for sovleplenib in immune thrombocytopenia

HUTCHMED (China) Limited, which is quoted on AIM andNasdaqunder LSE:HCM and in Hong Kong under 13, announced on 29 October 2026 that the US FDA has granted Orphan Drug Designation to sovleplenib for the treatment of primary immune thrombocytopenia, or ITP.

Ankur Sharma | 30 October 2026

Smith & Nephew Plc LSE:SN. Close higher?

The FTSE 100 more than reversed Monday's advance on Tuesday, ending the session close to 1% lower. Heavy falls in HSBC Holdings (LSE:HSBA) and Reckitt Benckiser (LSE:RKT) weighed on the index, while investors stayed cautious ahead of the UK Autumn Budget on Wednesday and …

Ishan Mudgal | 30 October 2026

IXICO (LSE:IXI) presents Huntington's disease imaging research at EHDN congress

IXICO plc, the AIM-quoted neuroscience imaging and biomarker analytics company, said on 29 October 2026 that it had presented new research at the European Huntington's Disease Network (EHDN) Clinical Research Congress 2026. The release was issued through a non-regulatory press release service, rather than …

Ankur Sharma | 30 October 2026

Feedback (LSE:FDBK) secures £127k QVH extension and £249k Bleepa funding, with cash runway to end of Q1 2027

Feedback plc, the AIM-quoted clinical infrastructure specialist with LSE:FDBK, published aBusinessupdate on 29 October 2026. The company said the announcement contained inside information under UK market abuse rules.

Ankur Sharma | 30 October 2026

Convatec Group Plc (LSE:CTEC) Advances 0.82%: What Is Supporting Investor Sentiment?

Convatec Group Plc — LSE:CTEC closed 0.82% higher on 30 October 2026, with the shares at 245.2p after an increase of 2.00p on the day.

Ishan Mudgal | 30 October 2026

Gsk Plc (LSE:GSK) Advances 2.48%: What Is Supporting Investor Sentiment?

Gsk Plc — LSE:GSK closed 2.48% higher on 30 October 2026, with the shares at 1,859.0p after an increase of 45.00p on the day.

Ishan Mudgal | 30 October 2026

Haleon Plc (LSE:HLN) Advances 1.83%: What Is Supporting Investor Sentiment?

Haleon Plc — LSE:HLN closed 1.83% higher on 30 October 2026, with the shares at 323.5p after an increase of 5.80p on the day.

Ishan Mudgal | 30 October 2026

Astrazeneca Plc (LSE:AZN) Advances 0.24%: What Is Supporting Investor Sentiment?

Astrazeneca Plc — LSE:AZN closed 0.24% higher on 30 October 2026, with the shares at 102.625p after an increase of 0.25p on the day.

Ishan Mudgal | 30 October 2026

SkinBioTherapeutics Plc (LSE:SBTX): Why This AIM market Stock Is in Focus on 30 October 2026 and What Comes Next

The centralInvestmentdebate combines clinical or commercial progress and funding visibility with the practical constraints of regulatory uncertainty, trial execution, commercial adoption and financing.

Ankur Sharma | 30 October 2026
Support

Hi! How can we help you today?

Loading…